Mainz Biomed N.V. financial data

Symbol
MYNZ on Nasdaq
Location
Robert Koch Strasse 50, Mainz, Germany
Fiscal year end
December 31
Latest financial report
20-F - Q4 2024 - Mar 31, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.32M shares -89%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1 USD
Research And Development Expense 9.59M USD +91.1%
General And Administrative Expense 11.4M USD -25%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 13.2M USD -14.1%
Liabilities 7.19M USD -40.9%